PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Ethanolic extract of P. caerulea demonstrated beneficial properties in an experimental colitis model related to inflammatory bowel disease [PMID:27596328]
An infusion of Melissa officinalis and Passiflora caerulea (200 mg/kg) in mice resulted in lower plasma corticosterone levels [PMID:23844268]
Aqueous fruit extract (PCAE) at 100 and 200 mg/kg in pilocarpine-induced epileptic mice delayed the onset of convulsions and improved alteration scores in the Y-maze test [PMID:31728889]
Administration of chrysin (1 mg/kg) to 2-year-old male rats led to increased libido, sperm count, fertilization potential, and litter size [PMID:12511112]
Ethanolic leaf extracts showed potency as an anticonvulsant (63% relative to carbamazepine), analgesic (70% relative to indomethacin), and anti-inflammatory (90% relative to indomethacin) [PMID:29844775]
Evidence summary
PubMed sources
- 1.PMID: 21613065 (2011) — B- and C-class gene expression during corona development of the blue passionflower (Passiflora caerulea, Passifloraceae). · American journal of botany
- 2.PMID: 38266002 (2024) — Machine learning-mediated Passiflora caerulea callogenesis optimization. · PloS one
- 3.PMID: 29161583 (2018) — Chrysin: Sources, beneficial pharmacological activities, and molecular mechanism of action. · Phytochemistry
- 4.PMID: 27596328 (2016) — Beneficial properties of Passiflora caerulea on experimental colitis. · Journal of ethnopharmacology
- 5.PMID: 37544907 (2023) — Force Generation in the Coiling Tendrils of Passiflora caerulea.